These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3355607)

  • 1. Metabolism of apolipoprotein C-III in normolipemic human subjects.
    Malmendier CL; Lontie JF; Grutman GA; Delcroix C
    Atherosclerosis; 1988 Jan; 69(1):51-9. PubMed ID: 3355607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects.
    Malmendier CL; Lontie JF; Grutman GA; Delcroix C
    Atherosclerosis; 1986 Nov; 62(2):167-72. PubMed ID: 3099803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
    Bukberg PR; Le NA; Ginsberg HN; Gibson JC; Rubinstein A; Brown WV
    J Lipid Res; 1985 Sep; 26(9):1047-57. PubMed ID: 4067427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-II and C-III metabolism in a kindred of familial hypobetalipoproteinemia.
    Malmendier CL; Delcroix C; Lontie JF; Dubois DY
    Metabolism; 1991 Jan; 40(1):45-50. PubMed ID: 1984570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III can specifically bind to hepatic plasma membranes.
    Fang DZ; Liu BW
    Mol Cell Biochem; 2000 Apr; 207(1-2):57-64. PubMed ID: 10888227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo E-containing lipoproteins in low or high density lipoprotein deficiency.
    Gibson JC; Rubinstein A; Brown WV; Ginsberg HN; Greten H; Norum R; Kayden H
    Arteriosclerosis; 1985; 5(4):371-80. PubMed ID: 3925935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
    Tomiyasu K; Walsh BW; Ikewaki K; Judge H; Sacks FM
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.
    Demant T; Seeberg K; Bedynek A; Seidel D
    Atherosclerosis; 2001 Aug; 157(2):325-39. PubMed ID: 11472732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles.
    Iriyama K; Nishiwaki H; Terashima H; Tonouchi H; Miki C; Suzuki H; Carpentier YA
    JPEN J Parenter Enteral Nutr; 1988; 12(1):60-2. PubMed ID: 3125357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I.
    Atger V; Duval F; Frommherz K; Drüeke T; Lacour B
    Atherosclerosis; 1988 Nov; 74(1-2):75-83. PubMed ID: 3145749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
    Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
    J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.